{"transactions":[{"id":1309547,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":84375,"kind":"person","name":"Karunatilake Chulani","position":1,"cik":"0001867326","reported_name":"Karunatilake Chulani","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T22:43:56.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":153129,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":153129,"derivative":{"exercise_price":1.56,"exercise_date":"2027-01-02","expiration_date":"2034-12-31","underlying":"Common Stock","underlying_shares":153129},"source":{"system":"sec-edgar","filing":"0000950170-25-002342","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000095017025002342/ownership.xml","form_type":"4"}},{"id":1309546,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":84375,"kind":"person","name":"Karunatilake Chulani","position":1,"cik":"0001867326","reported_name":"Karunatilake Chulani","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T22:43:56.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2025 with a Vesting Commencement Date of January 1, 2025. The shares underlying the option vest in equal monthly installments over four years, with the initial vesting to commence on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2029."}],"balance_after":150000,"derivative":{"exercise_price":1.56,"expiration_date":"2034-12-31","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-25-002342","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000095017025002342/ownership.xml","form_type":"4"}},{"id":1686820,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":84375,"kind":"person","name":"Karunatilake Chulani","position":1,"cik":"0001867326","reported_name":"Karunatilake Chulani","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:30:47.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2024 with a Vesting Commencement Date of January 1, 2024. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2028."}],"balance_after":150000,"derivative":{"exercise_price":4.64,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-24-001915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000095017024001915/ownership.xml","form_type":"4"}},{"id":2058288,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":84375,"kind":"person","name":"Karunatilake Chulani","position":1,"cik":"0001867326","reported_name":"Karunatilake Chulani","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-10T02:35:34.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":103600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 3, 2023 with a Vesting Commencement Date of January 1, 2023. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2027."}],"balance_after":103600,"derivative":{"exercise_price":2.05,"expiration_date":"2032-12-31","underlying":"Common Stock","underlying_shares":103600},"source":{"system":"sec-edgar","filing":"0000899243-23-001408","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924323001408/doc4.xml","form_type":"4"}},{"id":2243540,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":84375,"kind":"person","name":"Karunatilake Chulani","position":1,"cik":"0001867326","reported_name":"Karunatilake Chulani","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T20:40:37.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":136000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 1, 2022 with a Vesting Commencement Date of June 1, 2022. The shares underlying the option vest over three years, with the shares vesting in equal monthly installments through June 1, 2025."}],"balance_after":136000,"derivative":{"exercise_price":3.43,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":136000},"source":{"system":"sec-edgar","filing":"0000899243-22-020985","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924322020985/doc4.xml","form_type":"4"}},{"id":2433310,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":84375,"kind":"person","name":"Karunatilake Chulani","position":1,"cik":"0001867326","reported_name":"Karunatilake Chulani","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-18T23:29:44.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":34258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 6, 2022 with a Vesting Commencement Date of January 1, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through January 1, 2026."}],"balance_after":34258,"derivative":{"exercise_price":11.55,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":34258},"source":{"system":"sec-edgar","filing":"0000899243-22-002195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924322002195/doc4.xml","form_type":"4"}},{"id":2643365,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":84375,"kind":"person","name":"Karunatilake Chulani","position":1,"cik":"0001867326","reported_name":"Karunatilake Chulani","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-02T12:26:19.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":272000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on July 1, 2021. The shares underlying the option vest over four years, with one-fourth of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in equal monthly installments thereafter."}],"balance_after":272000,"derivative":{"exercise_price":19.23,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":272000},"source":{"system":"sec-edgar","filing":"0001785530-21-000030","document":"wf-form4_162522876528536.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000178553021000030/wf-form4_162522876528536.xml","form_type":"4"}}]}